

Amlin: Deutsche Bank upgrades to buy, target lifted from 420p to 435p. British Sky Broadcasting: Morgan Stanley upgrades to overweight, 790p target m...

Consort Medical said the first product to use its built-in dose counter had been given the go-ahead by the US Food and Drug Administration. Consort's...


Veterinary pharmaceutical firm Dechra Pharmaceuticals saw a slight fall in interim pre-tax profits and a softening of gross margins in its Services di...


Whitbread chief executive Andy Harrison made a firm declaration of his faith in the firm, purchasing nearly £200,000-worth of shares on the same day t...


Premier Farnell's share price had risen by more than 50% since the start of 2010 before yesterday's 9% fall, so a correction was probably inevitable a...


Drug inhaler maker Consort Medical reported a higher full-year pretax profit and said it expects continued revenue and profit growth, partly driven by...


Aggreko, the temporary power provider, saw its shares climb 5.5% amid expectations that it will be called in to help supply electricity to Japan's emb...


Drug inhaler firm Consort Medical has formed a strategic alliance with Atlas Genetics, a UK-based healthcare technology company with a point of care (...